Cargando…
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
Autores principales: | Marakasova, Ekaterina, Baranova, Ancha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858076/ https://www.ncbi.nlm.nih.gov/pubmed/33531391 http://dx.doi.org/10.1128/mBio.03447-20 |
Ejemplares similares
-
Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
por: Gold, Jeffrey E., et al.
Publicado: (2021) -
MR/MMR Vaccine in Measles Control: A Case of Missed Opportunity?
por: Sharma, Karun D, et al.
Publicado: (2014) -
Measles, misinformation, and risk: personal belief exemptions and the MMR vaccine
por: Bowes, Johnathan
Publicado: (2016) -
Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022) -
Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
por: Downey, Tina, et al.
Publicado: (2022)